Doma Perpetual Capital Management LLC Pacira Bio Sciences, Inc. Transaction History
Doma Perpetual Capital Management LLC
- $216 Billion
- Q2 2024
A detailed history of Doma Perpetual Capital Management LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Doma Perpetual Capital Management LLC holds 1,000,761 shares of PCRX stock, worth $14.7 Million. This represents 13.28% of its overall portfolio holdings.
Number of Shares
1,000,761
Previous 725,635
37.92%
Holding current value
$14.7 Million
Previous $21.2 Billion
35.04%
% of portfolio
13.28%
Previous 12.2%
Shares
3 transactions
Others Institutions Holding PCRX
# of Institutions
301Shares Held
51.5MCall Options Held
378KPut Options Held
1.53M-
Black Rock Inc. New York, NY8.01MShares$118 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$74.6 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.16MShares$31.7 Million0.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.07MShares$30.3 Million0.1% of portfolio
-
State Street Corp Boston, MA1.9MShares$27.9 Million0.0% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $673M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...